Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1981 Jul 1;154(1):77–87. doi: 10.1084/jem.154.1.77

Binding of bacillus Calmette-Guerin-activated macrophages to tumor targets. Selective inhibition by membrane preparations from homologous and heterologous neoplastic cells

PMCID: PMC2186396  PMID: 6788893

Abstract

The binding of tumor cells by activated macrophages is an initial and necessary event in the cytolysis of these targets. The data here indicate that membrane preparations from RL sigma 1 leukemia targets, EL-4 lymphoma targets, and P815 mastocytoma targets each inhibited binding of its homologous target to bacillus Calmette-Guerin (BCG)- activated murine macrophages in a dose-dependent fashion. Similar amounts of membrane from lymphocytes did not alter binding of the three neoplastic target to BCG-macrophages. Membranes of the three targets also inhibited binding of the heterologous neoplastic targets. Inhibitory activity of membrane preparations from P815, EL-4, and RL sigma 1 targets could be adsorbed by incubation of limiting concentrations of the membrane preparations with BCG-activated macrophages but not with thioglycollate broth-elicited macrophages. Exposure of BCG macrophages to membrane preparations from RL sigma 1, FL-4, or P815 targets inhibited subsequent cytolysis of the three targets. Inhibitory activity was increased in preparations enriched for plasma membrane. The data suggest that binding of three murine, nonadherent neoplastic targets to BCG-activated murine macrophages is mediated, in part, by recognition structures present within the plasma membranes of the three targets.

Full Text

The Full Text of this article is available as a PDF (745.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D. O. Effector mechanisms of cytolytically activated macrophages. I. Secretion of neutral proteases and effect of protease inhibitors. J Immunol. 1980 Jan;124(1):286–292. [PubMed] [Google Scholar]
  2. Adams D. O., Marino P. A. Evidence for a multistep mechanism of cytolysis by BCG-activated macrophages: the interrelationship between the capacity for cytolysis, target binding, and secretion of cytolytic factor. J Immunol. 1981 Mar;126(3):981–987. [PubMed] [Google Scholar]
  3. Adams D. O., Snyderman R. Do macrophages destroy nascent tumors? J Natl Cancer Inst. 1979 Jun;62(6):1341–1345. [PubMed] [Google Scholar]
  4. Crumpton M. J., Snary D. Preparation and properties of lymphocyte plasma membrane. Contemp Top Mol Immunol. 1974;3:27–56. doi: 10.1007/978-1-4684-2838-4_2. [DOI] [PubMed] [Google Scholar]
  5. Currie G. Immunological aspects of host resistance to the development and growth of cancer. Biochim Biophys Acta. 1976 Jul 16;458(2):135–165. doi: 10.1016/0304-419x(76)90004-4. [DOI] [PubMed] [Google Scholar]
  6. Fidler I. J., Roblin R. O., Poste G. In vitro tumoricidal activity of macrophages against virus-transformed lines with temperature-dependent transformed phenotypic characteristics. Cell Immunol. 1978 Jun;38(1):131–146. doi: 10.1016/0008-8749(78)90039-4. [DOI] [PubMed] [Google Scholar]
  7. Freedman V. H., Calvelli T. A., Silagi S., Silverstein S. C. Macrophages elicited with heat-killed bacillus Calomette-Guérin protect C57BL/6J mice against a syngeneic melanoma. J Exp Med. 1980 Sep 1;152(3):657–673. doi: 10.1084/jem.152.3.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gilmer P. J., McDevitt H. O., McConnell H. M. Inhibition of specific effector T cell-target cell conjugates by cell plasma membranes. J Immunol. 1978 Mar;120(3):774–776. [PubMed] [Google Scholar]
  9. Hibbs J. B., Jr, Chapman H. A., Jr, Weinberg J. B. The macrophage as an antineoplastic surveillance cell: biological perspectives. J Reticuloendothel Soc. 1978 Nov;24(5):549–570. [PubMed] [Google Scholar]
  10. Koren H. S., Meltzer M. S., Adams D. O. The ADCC capacity of macrophages from C3H/HeJ and A/J mice can be augmented by BCG. J Immunol. 1981 Mar;126(3):1013–1015. [PubMed] [Google Scholar]
  11. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  12. Linna T. J., Engers H. D., Cerottini J. C., Brunner K. T. Inhibition of cytolytic T lymphocyte activity with subcellular alloantigen preparations and with unlabeled allogeneic target cells. J Immunol. 1978 May;120(5):1544–1549. [PubMed] [Google Scholar]
  13. Marino P. A., Adams D. O. Interaction of Bacillus Calmette--Guérin-activated macrophages and neoplastic cells in vitro II. The relationship of selective binding to cytolysis. Cell Immunol. 1980 Aug 15;54(1):26–35. doi: 10.1016/0008-8749(80)90186-0. [DOI] [PubMed] [Google Scholar]
  14. Marino P. A., Adams D. O. Interaction of Bacillus Calmette--Guérin-activated macrophages and neoplastic cells in vitro. I. Conditions of binding and its selectivity. Cell Immunol. 1980 Aug 15;54(1):11–25. doi: 10.1016/0008-8749(80)90185-9. [DOI] [PubMed] [Google Scholar]
  15. Meltzer M. S., Tucker R. W., Breuer A. C. Interaction of BCG-activated macrophages with neoplastic and noneoplastic cell lines in vitro: cinemicrographic analysis. Cell Immunol. 1975 May;17(1):30–42. doi: 10.1016/s0008-8749(75)80004-9. [DOI] [PubMed] [Google Scholar]
  16. Meltzer M. S., Tucker R. W., Sanford K. K., Leonard E. J. Interaction of BCG-activated macrophages with neoplastic and nonneoplastic cell lines in vitro : quantitation of the cytotoxic reaction by release of tritiated thymidine from prelabeled target cells. J Natl Cancer Inst. 1975 May;54(5):1177–1184. doi: 10.1093/jnci/54.5.1177. [DOI] [PubMed] [Google Scholar]
  17. Muramatsu T., Gachelin G., Nicolas J. F., Condamine H., Jakob H., Jacob F. Carbohydrate structure and cell differentitation: unique properties of fucosyl-glycopeptides isolated from embryonal carcinoma cells. Proc Natl Acad Sci U S A. 1978 May;75(5):2315–2319. doi: 10.1073/pnas.75.5.2315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Piessens W. F. Increased binding of tumor cells by macrophages activated in vitro with lymphocyte mediators. Cell Immunol. 1978 Feb;35(2):303–317. doi: 10.1016/0008-8749(78)90151-x. [DOI] [PubMed] [Google Scholar]
  19. Snodgrass M. J., Harris T. M., Geeraets R., Kaplan A. M. Motility and cytotoxicity of activated macrophages in the presence of carcinoma cells. J Reticuloendothel Soc. 1977 Aug;22(2):149–157. [PubMed] [Google Scholar]
  20. Todd R. F., Stulting R. D., Amos D. B. Lymphocyte-mediated cytolysis of allogeneic tumor cells in vitro. I. Search for target antigens in subcellular fractions. Cell Immunol. 1975 Aug;18(2):304–323. doi: 10.1016/0008-8749(75)90059-3. [DOI] [PubMed] [Google Scholar]
  21. Whisnant C. C., Singer K. H., Amos D. B. Interaction of cytotoxic T lymphocytes with target cells. I. Specific inhibition by detergent-solubilized, partially purified mouse histocompatibility antigens. J Immunol. 1978 Dec;121(6):2253–2256. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES